发明名称 Nuclear magnetic resonance-docking of compounds
摘要 The invention provides a method for determining a structure model for a test ligand bound to a macromolecule binding site. Structural constraints for the test ligand are derived from spectroscopic signals arising from interactions between the test ligand and macromolecule. The structure constraints are used as constraints in docking a structure model of the ligand to a structure model of the macromolecule, or as constraints in overlaying a structure model of the test ligand on the known structure for a reference ligand that binds to the macromolecule. The invention further provides a method for determining a structure model for a macromolecule bound to a ligand. Structural constraints derived from spectroscopically observed interactions of the macromolecule and a reference ligand are used to guide molecular modeling or to evaluate the results of a molecular modeling simulation of the macromolecule.
申请公布号 US2005234652(A1) 申请公布日期 2005.10.20
申请号 US20050115850 申请日期 2005.04.26
申请人 TRIAD THERAPEUTICS, INC. 发明人 SEM DANIEL S.;PELLECCHIA MAURIZIO
分类号 G01N24/08;G01R33/46;G01R33/465;(IPC1-7):G06F19/00;G01N33/48;G01N33/50 主分类号 G01N24/08
代理机构 代理人
主权项
地址